In Rossi V. et al's study, 1,150 early-stage BC patients who underwent curative surgery were analyzed and the authors found that a HER2 2+, but FISH negative was a prognostic indicator for poor prognosis of operable BC patients [16]. This evidence concerns the gene ERBB2 and breast cancer.